Eculizumab er et humaniseret monoklonalt IgG2/ 4κ- antistof, der er produceret i en NS0- cellelinje ved rekombinant dna- teknologi.
Eculizumab is a humanised monoclonal IgG2/ 4κ antibody produced in NS0 cell line by recombinant DNA technology.